|
Abnormal renal morphology
|
0.010 |
Biomarker
|
disease |
BEFREE |
Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations.
|
11073823 |
2000 |
|
Abnormal subcutaneous fat tissue distribution
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Abnormality of pelvic girdle bone morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Abnormality of the humerus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Abnormality of the ulna
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Abnormality of tibia morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Abortion, Tubal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Gene expression in cultured endometrium from women with different outcomes following IVF.
|
18539642 |
2008 |
|
Acoustic Neuroma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Gene expression profiles of artemin, BDNF, GDNF, TGF-beta1/beta2 and Ret were determined in the vestibular schwannoma in comparison to the peripheral nerve tissues by using semiquantitative RT-PCR.
|
19937367 |
2010 |
|
Acoustic Neuroma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The objective of the present study was to investigate the expression level and the localization of the pro-inflammatory cytokines, transforming growth factor-β1 (TGF-β1) interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α), as well as the adhesion molecules, intracellular adhesion molecule-1 and vascular endothelial growth factor (VEGF), in order to determine whether these factors are involved in the transformation and development of human vestibular schwannoma.
|
25738867 |
2015 |
|
Acquired aplastic anemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Subsequent in vitro experiments revealed that 1,25(OH)2 D3 treatment suppressed the proliferation of lymphocytes and inhibited the secretion of interferon-γ, tumor necrosis factor-α, and interleukin-17A, meanwhile promoting the production of transforming growth factor-β1 in patients with AA.
|
26152509 |
2016 |
|
Acquired aplastic anemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
This initial analysis provides valuable clues for further study of TGF-β1 pathway genes in acquired AA.
|
27933374 |
2017 |
|
Acromicric Dysplasia
|
0.300 |
Biomarker
|
disease |
CTD_human |
ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.
|
18677313 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.300 |
Biomarker
|
disease |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Acute Chest Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
The CC genotype and the C allele of TGF-β1 might be a specific risk factor of ACS in the Chinese Han population in Xinjiang.
|
24737521 |
2014 |
|
Acute Chest Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
We found ACS patients had a significantly lower frequency of circulating CD4(+)LAP(+) Tregs, and the function of these cells was reduced compared to controls.
|
24558424 |
2014 |
|
Acute Chest Syndrome
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
In contrast, Treg cell population, Foxp3 levels, and plasma TGF-β1 were decreased in ACS patients compared with stable angina (SA) and NCA patients.
|
21524750 |
2011 |
|
Acute Chest Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
The results suggest that TGF-β1 T29C gene polymorphism could be involved in the risk of developing ACS in Mexican individuals.
|
22465044 |
2012 |
|
Acute Chest Syndrome
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
The aim was to measure the plasma levels of TGF-β1, 2, and 3 proteins in patients with ACS.
|
30003432 |
2018 |
|
Acute colitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
|
17786278 |
2007 |
|
Acute Coronary Syndrome
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The aim of the present study was to evaluate the role of TGF-β1 gene polymorphisms as susceptibility markers for acute coronary syndrome (ACS).
|
22465044 |
2012 |
|
Acute Coronary Syndrome
|
0.040 |
AlteredExpression
|
disease |
LHGDN |
Transcriptional activity of genes encoding Transforming Growth Factor beta and its receptors in peripheral blood mononuclear cells from patients with acute coronary syndromes.
|
16307809 |
2006 |
|
Acute Coronary Syndrome
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Association of a transforming growth factor-β1 polymorphism with acute coronary syndrome in a Chinese Han population.
|
24737521 |
2014 |
|
Acute Coronary Syndrome
|
0.040 |
Biomarker
|
disease |
BEFREE |
CD4(+) latency-associated peptide (LAP)(+) regulatory T cells (Tregs) are a newly discovered T cell subset in humans and the role of these cells in patients with acute coronary syndrome (ACS) has not been explored.
|
24558424 |
2014 |
|
Acute Erythroblastic Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
Transforming growth factor-beta 1 (TGF beta 1) can induce hemoglobin accumulation in a clone of the human HEL erythroleukemia cell line.
|
1895755 |
1991 |
|
Acute Erythroblastic Leukemia
|
0.040 |
Biomarker
|
disease |
BEFREE |
We have examined the effects of TGF beta 1 and TGF beta 2 on the HEL human erythroleukemia cell line.
|
2590216 |
1989 |